Medicines Co. (MDCO) Reports Q2 Loss of $1.02/Share
Tweet
Share
E-mail
Get Alerts MDCO Hot Sheet
Price: $84.90 --0%
Financial Fact:
Selling, general and administrative: 69.02M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Selling, general and administrative: 69.02M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Medicines Co. (NASDAQ: MDCO) reported Q2 EPS of ($1.02), versus ($0.69) reported last year. Revenue for the quarter came in at $18.7 million, versus $54.73 million reported last year.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- XP Inc eyes US banking license as next business step
- Duos Technologies Group, Inc. (DUOT) Tops Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
